<DOC>
	<DOC>NCT00798486</DOC>
	<brief_summary>The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.</brief_summary>
	<brief_title>Evaluation of the A1CNow+ Test Kit</brief_title>
	<detailed_description>The purpose of this study was to assure that consumers could successfully use the new version of A1CNow+ Test Kit along with revised instructional materials. The primary objective was to establish accuracy and secondary objectives were to establish precision, comprehension of instructional materials, and user feedback about the overall testing experience.</detailed_description>
	<criteria>1. Adults (age 18 and older) approximately 80% being â‰¤55 years old 2. Persons with: known diabetes (type 1 or type 2) and prediabetes approximately 85% of subject population per site no known diagnosis of diabetes approximately 15% of subject population per site 3. Individuals who are interested in performing a test using the kit at home 4. Individuals willing to complete all study procedures (including venous draw and allowing site staff to perform finger punctures) 5. Individuals who are able to speak, read, and understand English 6. Individuals able to read out loud the first 5 lines of the A1C Test Kit instructional materials to demonstrate ability to read the print (may use glasses, if needed) 1. Individuals taking prescription anticoagulants (such as Warfarin or heparin) or have clotting problems that may prolong bleeding. (Taking Plavix or aspirin daily is not excluded) 2. Individuals with known Rheumatoid Arthritis or other condition causing significant impairment of manual dexterity 3. Individuals with a known hemoglobin variant such as HbS or HbC 4. Individuals with any known disorder of the blood or bloodforming organs (such as recovery from blood loss, hemolytic anemia, or iron deficiency anemia) 5. Individuals who have received a blood transfusion within the 4 months prior to the study. 6. Persons with known infection with a bloodborne pathogen (e.g. HIV, hepatitis) 7. Individuals working for a competitive medical device company 8. Individuals who have participated in previous studies on the A1CNow+ product 9. Persons missing a digit or partial digits on the hand 10. Individuals with the following impairments which, in the opinion of the investigator, would seriously compromise the integrity of the study: Significant visual impairment Significant hearing impairment Cognitive disorder Any other condition as per investigator's discretion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>